Publications

Export 3 results:
Author [ Title(Desc)] Type Year
Filters: Author is Bandeira, Igor D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Correia-Melo FS, Leal GC, Vieira F, Jesus-Nunes APaula, Mello RP, Magnavita G, Caliman-Fontes ATeresa, Echegaray MVF, Bandeira ID, Silva SS et al..  2019.  Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.. J Affect Disord.
I
Leal GC, Bandeira ID, Correia-Melo FS, Telles M, Mello RP, Vieira F, Lima CS, Jesus-Nunes APaula, Guerreiro-Costa LNF, Marback RF et al..  2020.  Intravenous arketamine for treatment-resistant depression: open-label pilot study.. Eur Arch Psychiatry Clin Neurosci.
K
Vieira F, Correia-Melo FS, Santos-Lima C, Souza-Marques B, Leal GC, Jesus-Nunes APaula, Mello RP, Caliman-Fontes ATeresa, Bandeira ID, Marback RF et al..  2021.  Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial.. Gen Hosp Psychiatry. 68:97-99.